StockData
Humana Inc logo

Humana Inc (HUM) stock

HUMNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/3049% above fair value
$443.34−17.91 (-3.88%)

Close on Nov 17, 2026Market cap $53.24BP/E 41.8Yield 0.80%

Humana free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Humana's free cash flow for the twelve months ending Jun 30, 2026 was $1.95B, down 20.1% year over year. For fiscal 2025 it was $375.00M, down 84.3% from the year before. Over ten years it grew 0.8% a year on average. The highest annual figure on record is $4.68B in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$375.00M-84.3%
FY2024Dec 31, 2024$2.39B-19.7%
FY2023Dec 31, 2023$2.98B-13.7%
FY2022Dec 31, 2022$3.45B+275.0%
FY2021Dec 31, 2021$920.00M-80.3%
FY2020Dec 31, 2020$4.68B+2.8%
FY2019Dec 31, 2019$4.55B+191.4%
FY2018Dec 31, 2018$1.56B-55.7%
FY2017Dec 31, 2017$3.53B+150.3%
FY2016Dec 31, 2016$1.41B+308.4%
FY2015Dec 31, 2015$345.00M-68.3%
FY2014Dec 31, 2014$1.09B-14.5%
FY2013Dec 31, 2013$1.28B-15.7%
FY2012Dec 31, 2012$1.51B-12.7%
FY2011Dec 31, 2011$1.73B-14.2%
FY2010Dec 31, 2010$2.02B+63.3%
FY2009Dec 31, 2009$1.24B+71.6%
FY2008Dec 31, 2008$720.74M-26.8%
FY2007Dec 31, 2007$985.02M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.83B+58.5%
Q1 FY2026Mar 31, 2026$1.13B+380.1%
Q4 FY2025Dec 31, 2025-$1.85B–
Q3 FY2025Sep 30, 2025$836.00M-51.6%
Q2 FY2025Jun 30, 2025$1.16B+5.3%
Q1 FY2025Mar 31, 2025$236.00M-4.1%
Q4 FY2024Dec 31, 2024-$682.00M–
Q3 FY2024Sep 30, 2024$1.73B+69.7%
Q2 FY2024Jun 30, 2024$1.10B-62.3%
Q1 FY2024Mar 31, 2024$246.00M-96.2%
Q4 FY2023Dec 31, 2023-$7.42B–
Q3 FY2023Sep 30, 2023$1.02B-87.5%
Q2 FY2023Jun 30, 2023$2.91B+328.2%
Q1 FY2023Mar 31, 2023$6.46B+92242.9%
Q4 FY2022Dec 31, 2022-$5.40B–
Q3 FY2022Sep 30, 2022$8.17B+225.4%
Q2 FY2022Jun 30, 2022$680.00M+2093.5%
Q1 FY2022Mar 31, 2022$7.00M–
Q4 FY2021Dec 31, 2021-$493.00M–
Q3 FY2021Sep 30, 2021$2.51B+60.3%
Q2 FY2021Jun 30, 2021$31.00M-98.9%
Q1 FY2021Mar 31, 2021-$1.13B-499.6%
Q4 FY2020Dec 31, 2020-$13.00M-104.6%
Q3 FY2020Sep 30, 2020$1.57B-29.9%
Q2 FY2020Jun 30, 2020$2.84B+122.5%
Q1 FY2020Mar 31, 2020$282.00M-62.7%
Q4 FY2019Dec 31, 2019$282.00M–
Q3 FY2019Sep 30, 2019$2.23B–
Q2 FY2019Jun 30, 2019$1.28B–
Q1 FY2019Mar 31, 2019$757.00M-78.7%
Q4 FY2018Dec 31, 2018-$509.00M–
Q3 FY2018Sep 30, 2018-$1.22B-144.8%
Q2 FY2018Jun 30, 2018-$263.00M–
Q1 FY2018Mar 31, 2018$3.55B-13.0%
Q4 FY2017Dec 31, 2017-$3.06B–
Q3 FY2017Sep 30, 2017$2.72B-37.7%
Q2 FY2017Jun 30, 2017-$217.00M–
Q1 FY2017Mar 31, 2017$4.08B–
Q4 FY2016Dec 31, 2016-$2.91B–
Q3 FY2016Sep 30, 2016$4.36B–

More Humana figures

See a number that looks wrong?